Tyngsborough, MA, United States of America

Thomas Rawlins

This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignee: Revvity Health Sciences, Inc.. Active years: 2025-2026.

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 4.9

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Thomas Rawlins

Introduction

Thomas Rawlins is an accomplished inventor based in Tyngsborough, MA (US). He has made significant contributions to the field of microfluidics and automated pipetting systems. With a total of 3 patents, Rawlins continues to push the boundaries of technology in health sciences.

Latest Patents

Rawlins' latest patents include a microfluidic chip and an electrical interface for microchip electrophoresis. This microfluidic system features a non-conductive substrate with wells connected to a microfluidic channel. Each well has a galvanic contact that interacts with a plurality of electrodes as part of an electrical interface. The system is designed to generate power signals, enhancing the efficiency of microchip electrophoresis. Additionally, he has developed an automated pipetting system that includes a pipettor with dual plunger mechanisms. This innovative design allows for precise control over liquid aspiration and dispensing.

Career Highlights

Thomas Rawlins is currently employed at Revvity Health Sciences, Inc., where he applies his expertise in developing cutting-edge technologies. His work has been instrumental in advancing the capabilities of automated laboratory systems.

Collaborations

Some of his notable coworkers include Michael W Belobraydich and Vladimir Krasheninin, who contribute to the innovative environment at Revvity Health Sciences.

Conclusion

Thomas Rawlins exemplifies the spirit of innovation in the health sciences sector. His patents and contributions are paving the way for advancements in microfluidics and automated systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…